Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease

Vaccine

Volumn 29, Issue 2, 2010, Pages 283-288

  Yildirim, Inci ^a,b   Hanage, William P ^c   Lipsitch, Marc ^c   Shea, Kimberly M ^a,b   Stevenson, Abbie ^a   Finkelstein, Jonathan ^d   Huang, Susan S ^e,f   Lee, Grace M ^d   Kleinman, Ken ^d   Pelton, S I ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Invasive capacity; Serotype; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE;

ARTICLE; BACTERIAL COLONIZATION; CHILD; DISEASE SURVEILLANCE; HUMAN; INCIDENCE; NASOPHARYNX; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

CARRIER STATE; CHILD; CHILD, PRESCHOOL; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MASSACHUSETTS; PNEUMOCOCCAL INFECTIONS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 78649698890     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.10.032     Document Type: Article

References (28)

1. Hausdorff W.P., Feikin D.R., Klugman K.P. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 2005, 5(2):83-93.
2. Huang S.S., Platt R., Rifas-Shiman S.L., Pelton S.I., Goldmann D., Finkelstein J.A. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 2005, 116(3):e408-e413.
3. Weinberger D.M., Trzcinski K., Lu Y.J., Bogaert D., Brandes A., Galagan J., et al. Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathog 2009, 5(6):e1000476.
4. Sabharwal V., Ram S., Figueira M., Park I.H., Pelton S.I. Role of complement in host defense against pneumococcal otitis media. Infect Immun 2009, 77(3):1121-1127.
5. Kostyukova N.N., Volkova M.O., Ivanova V.V., Kvetnaya A.S. A study of pathogenic factors of Streptococcus pneumoniae strains causing meningitis. FEMS Immunol Med Microbiol 1995, 10(2):133-137.
6. Malley R., Lipsitch M., Stack A., Saladino R., Fleisher G., Pelton S., et al. Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci. Infect Immun 2001, 69(8):4870-4873.
7. Hausdorff W.P., Bryant J., Paradiso P.R., Siber G.R. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 2000, 30(1):100-121.
8. Beall B., McEllistrem M.C., Gertz R.E., Wedel S., Boxrud D.J., Gonzalez A.L., et al. Pre- and post-vaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002. J Clin Microbiol 2006, 44(3):999-1017.
9. Pilishvili T., Lexau C., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010, 201(1):32-41.
10. Hanage W.P., Huang S.S., Lipsitch M., Bishop C.J., Godoy D., Pelton S.I., et al. Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era. J Infect Dis 2007, 195(3):347-352.
11. Huang S.S., Hinrichsen V.L., Stevenson A.E., Rifas-Shiman S.L., Kleinman K., Pelton S.I., et al. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics 2009, 124(1):e1-11.
12. Moore M.R., Hyde T.B., Hennessy T.W., Parks D.J., Reasonover A.L., Harker-Jones M., et al. Impact of a conjugate vaccine on community-wide carriage of non-susceptible Streptococcus pneumoniae in Alaska. J Infect Dis 2004, 190(11):2031-2038.
13. Brueggemann A.B., Peto T.E., Crook D.W., Butler J.C., Kristinsson K.G., Spratt B.G. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis 2004, 190(7):1203-1211.
14. Shouval D.S., Greenberg D., Givon-Lavi N., Porat N., Dagan R. Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis. Pediatr Infect Dis J 2006, 25(7):602-607.
15. Lagos R., Munoz A., San Martin O., Maldonado A., Hormazabal J.C., Blackwelder W.C., et al. Age- and serotype-specific pediatric invasive pneumococcal disease: insights from systematic surveillance in Santiago, Chile, 1994-2007. J Infect Dis 2008, 198(12):1809-1817.
16. Brueggemann A.B., Griffiths D.T., Meats E., Peto T., Crook D.W., Spratt B.G. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 2003, 187(9):1424-1432.
17. Hanage W.P., Kaijalainen T.H., Syrjanen R.K., Auranen K., Leinonen M., Makela P.H., et al. Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland. Infect Immun 2005, 73(1):431-435.
18. Smith T., Lehmann D., Montgomery J., Gratten M., Riley I.D., Alpers M.P. Acquisition and invasiveness of different serotypes of Streptococcus pneumoniae in young children. Epidemiol Infect 1993, 111(1):27-39.
19. Hsu K.K., Shea K.M., Stevenson A.E., Pelton S.I. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007. Pediatr Infect Dis J 2010, 29(4):289-293.
20. Hsu K, Shea KM, Stevenson AE, Pelton S. Underlying conditions in children with invasive pneumococcal disease in the conjugate vaccine era. Pediatr Infect Dis J; in press, doi:10.1097/INF.0b013e3181fab1cf.
21. Armitage S.S.C.T. Encylclopedia of biostatistics 2005, John Wiley & Sons Hobooken, NJ. 2nd ed.
22. Hanley J.A., Lippman-Hand A. If nothing goes wrong, is everything all right? Interpreting zero numerators. JAMA 1983, 249(13):1743-1745.
23. Progress in introduction of pneumococcal conjugate vaccine worldwide, 2000-2008. MMWR 2008, 57:1148-1151.
24. Hsu K., Pelton S., Karumuri S., Heisey-Grove D., Klein J. Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine. Pediatr Infect Dis J 2005, 24(1):17-23.
25. Dagan R., Givon-Lavi N., Fraser D., Lipsitch M., Siber G.R., Kohberger R. Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus. J Infect Dis 2005, 192(3):367-376.
26. Lipsitch M., Whitney C.G., Zell E., Kaijalainen T., Dagan R., Malley R. Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease?. PLoS Med 2005, 2(1):e15.
27. Malley R., Stack A.M., Ferretti M.L., Thompson C.M., Saladino R.A. Anticapsular polysaccharide antibodies and nasopharyngeal colonization with Streptococcus pneumoniae in infant rats. J Infect Dis 1998, 178(3):878-882.
28. Bogaert D., De Groot R., Hermans P.W. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 2004, 4(3):144-154.